European Patent Office

T 1772/09 of 05.07.2013

European Case Law Identifier
ECLI:EP:BA:2013:T177209.20130705
Date of decision
5 July 2013
Case number
T 1772/09
Petition for review of
-
Application number
02782507.4
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF
Applicant name
OTSUKA PHARMACEUTICAL CO., LTD.
Opponent name
Teva Pharmaceutical Industries Ltd.
Fermion Oy
Pharmaceutical Works POLPHARMA
EGIS Gyógyszergyár Nyrt
Ratiopharm GmbH
Board
3.3.01
Headnote
-
Relevant legal provisions
European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 83European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 13Rules of procedure of the Boards of Appeal Art 15(3)
Keywords
Late-filed documents: Admission (yes)
Main request: Added subject-matter (no); sufficiency of disclosure (no)
First auxiliary request: Added subject-matter (no); sufficiency of disclosure (yes); novelty (yes) - not inevitable result of prior-art process
Remittal to the department of first instance
Catchword
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the department of first

instance for further prosecution.